Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Drug Discovery And Development

Giving chemotherapy after radiotherapy improves survival for patients with rare brain tumour

Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years.

Cancer Research Technology Pioneer Fund boosts investment in drugs that block cancer defences

The Cancer Research Technology (CRT) Pioneer Fund has today announced its investment in research to develop new drugs.

Mapping cancer’s ‘social networks’ opens new approaches to treatment

Cancer Research UK scientists have designed a computer model that applies techniques used to analyse social networks to identify new ways of treating cancer.

Discovery could lead to more targeted drugs to stop cancer spread

Scientists have shed more light on a vital cluster of proteins that helps cells – including cancer cells – to move around the body

Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge

A new laboratory has been opened this week in Cambridge by life sciences minister George Freeman MP

BACIT seeks shareholder approval to commit £20m and join CRT Pioneer Fund as a limited partner

BACIT is seeking shareholder approval to permit an investment into the CRT Pioneer Fund, taking the total to £70m.

Cancer Research UK increases investment in drug development

Cancer Research UK is to increase investment by nearly 50 per cent over the next five years in its Centre for Drug Development.

International deal to screen potential cancer drugs using DNA 'barcodes'

A screening technology tags compounds with strands of DNA to assess prototype drugs for anti-cancer activity.

Cancer Research UK and Lilly collaborate to trial combinations of potential new cancer treatments

Cancer Research UK's Drug Development Office announced that Eli Lilly will join its Combinations Alliance to help discover medicines for cancer.

CRT announces partnership with Cephalon to co-develop a new class of anti-cancer drugs

Cancer Research Technology (CRT) has announced an exclusive agreement with Cephalon, Inc., an international biotechnology company, to collaborate on the development of...

Pages